Progressive Radio Network

The CDC’s Advisory Panel on Immunization Practices (ACIP) recommended that the FluMist nasal influenza vaccine should be taken off the shelves for the 2016-2017 flu season, noting the vaccine’s protection rate last year was a dismal 3 percent, which means that no protective benefit could be gauged. ................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download